For investors

Xrike in one minute.

The movement platform for human potential. A compact, drill-free physical platform that is in market today, with an intelligence layer being built on top of it.

Concept film. Capabilities shown are in design or development. The physical product is IP-protected and is shown under NDA.

The problem

Nothing watches how people move.

Nearly one in three adults does not move enough, and 1.71 billion people live with a musculoskeletal condition. Nothing in daily life watches how people move and guides them while they do.

Sources: Lancet Global Health, 2024 · WHO musculoskeletal fact sheet

What we are building

A physical platform, then the intelligence.

A drill-free, modular platform with 360° access and hundreds of progressions, guided by The Xrike Method, co-developed with our clinical advisors. Xrivah, our AI layer, is being built on top.

Where we are

Status, lane by lane.

  • Physical platform In market
  • The Xrike Method Defined
  • Computer vision Proof of concept
  • Sensing, adaptive resistance, Xrivah In design
Why we can win

The integration is the edge.

Vision, sensing and adaptive resistance each exist today. Our edge is joining them on one platform, guided by a method and governed by guardrails. A patent has been filed.

Traction

Already sold. Bootstrapped.

Hardware has been sold, and the founders have funded the company themselves, with revenue reinvested. DPIIT-recognised, with manufacturing and distribution partners in place.

Where we start

Everyday wellness and the workplace.

India first, with the UAE next. Performance, hospitality and clinical settings follow on the same core.

The founders

Suresh and Maria Augustine.

Suresh, Founder and CEO: about 27 years in enterprise technology and manufacturing, including IBM and GE Medical Systems. Maria, Co-Founder and Director: a background in education, applied to how the method is built. Our story

What we are looking for

Investors who back deep-tech platforms.

Investors, grant programmes and partners who can help us reach customers. We share architecture and evidence under NDA.

The physical platform is IP-protected, with design registration pending. Pictures and design detail are shared under NDA, and we expect to disclose it publicly in early 2027. Xrike is an early-stage company, and nothing here is a clinical claim.